IGF-IR signal transduction protein content and its activation by IGF-I in human placentas: Relationship with gestational age and birth weight

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Iñiguez, Germán ^a   Castro, Juan José ^a   Garcia, Mirna ^a   Kakarieka, Elena ^a   Johnson, M Cecilia ^a   Cassorla, Fernando ^a   Mericq, Verónica ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; PLACENTA PROTEIN; PROTEIN KINASE B; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; MTOR PROTEIN, HUMAN; TARGET OF RAPAMYCIN KINASE;

ARTICLE; BIRTH WEIGHT; BODY HEIGHT; CONTROLLED STUDY; ENZYME ACTIVATION; GESTATIONAL AGE; HUMAN; NEWBORN; PLACENTA; PLACENTA WEIGHT; PREMATURITY; PROTEIN CONTENT; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TERM BIRTH; FEMALE; INTRAUTERINE GROWTH RETARDATION; LOW BIRTH WEIGHT; MALE; METABOLISM; PHYSIOLOGY; PREGNANCY; TISSUE CULTURE TECHNIQUE;

BIRTH WEIGHT; FEMALE; FETAL GROWTH RETARDATION; GESTATIONAL AGE; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INSULIN-LIKE GROWTH FACTOR I; MALE; PLACENTA; PREGNANCY; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, IGF TYPE 1; SIGNAL TRANSDUCTION; TISSUE CULTURE TECHNIQUES; TOR SERINE-THREONINE KINASES;

EID: 84904701249     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0102252     Document Type: Article

References (35)

1. Resnik R (2002) Intrauterine growth restriction. Obstet Gynecol; 99:490-496.
2. Low JA, Handley-Derry MH, Burke SO, Peters RD, Pater EA, et al. (1992) Association of intrauterine fetal growth retardation and learning deficits at age 9 to 11 years. Am J Obstet Gynecol 167:1499-1505. (Pubitemid 23009276)
3. Kramer MS, Olivier M, McLean FH, Willis DM, Usher RH (1990) Impact of intrauterine growth retardation and body proportionality on fetal and neonatal outcome. Pediatrics 86:707-713. (Pubitemid 20379399)
4. Hattersley AT, Tooke JE (1999) The fetal insulin hypothesis: an alternative explanation of the association of low birth weight with diabetes and vascular disease. Lancet 353:1789-1792. (Pubitemid 29240389)
5. Barker DJ (2004) The developmental origins of well-being. Philos Trans R Soc Lond B Biol Sci 359:1359-1366.
6. Ge WJ, Mirea L, Yang J, Bassil KL, Lee SK, et al. (2013) Prediction of neonatal outcomes in extremely preterm neonates. Pediatrics. 132(4):e876-85.
7. Institute of Medicine (US) Committee on Understanding Premature Birth and Assuring Healthy Outcomes, Behrman RE, Butler AS (2007) Preterm Birth: Causes, Consequences, and Prevention. Washington, DC: National Academies Press.
8. DeChiara TM, Efstratiadis A, Robertson EJ (1990) A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature; 345:78-80.
9. Baker J, Liu JP, Robertson EJ, Efstratiadis A (1993) A role of insulin-like growth factors in embryonic and postnatal growth. Cell 75:73-82. (Pubitemid 23306022)
10. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A (1993) Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75:59-72. (Pubitemid 23306021)
11. Fowden AL (2003) The insulin-like growth factors and feto-placental growth. Placenta 24:803-812.
12. Han VK, Carter AM (2000) Spatial and temporal patterns of expression of messenger RNA for insulin-like growth factors and their binding proteins in the placenta of man and laboratory animals. Placenta 21:289-305. (Pubitemid 30364862)
13. Iñiguez G, Argandoña F, Medina P, González C, San Martin S, et al. (2011) Acid-labile subunit (ALS) gene expression and protein content in human placentas: differences according to birth weight. J Clin Endocrinol Metab 96(1):187-91.
14. Bornfeldt KE, Raines EW, Nakano T, Graves LM, Krebs EG, et al. (1994) Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation. J Clin Invest 93: 1266-1274. (Pubitemid 24087183)
15. White MF (1997) The insulin signalling system and the IRS proteins. Diabetologia (Suppl. 2):S2-S17.
16. White MF (2002) IRS proteins and the common path to diabetes. Am. J. Physiol. Endocrinol. Metab. 283:E413-E422.
17. Foulstone E, Prince S, Zaccheo O, Burns JL, Harper J, et al. (2005) Insulin-like growth factor ligands, receptors, and binding proteins in cancer. J. Pathol. 205:145-153. (Pubitemid 40227987)
18. Milad M, Novoa JM, Fabres J, Samame MM, Aspillaga C (2010) Recomendación sobre Curvas de Crecimiento Intrauterino. Rev. Chil. Pediatr. 81 (3): 264-274.
19. Harris LK, Crocker IP, Baker PN, Aplin JD, Westwood M (2011) IGF2 actions on trophoblast in human placenta are regulated by the insulin-like growth factor 2 receptor, which can function as both a signaling and clearance receptor. Biol Reprod. 84(3):440-6.
20. Iñiguez G, González CA, Argandoña F, Kakarieka E, Johnson MC, et al., (2010) Expression and protein content of IGF-I and IGF-I receptor in placentas from small, adequate and large for gestational age newborns. Horm Res Paediatr 73(5):320-7.
21. Abu-Amero SN, Ali Z, Bennett P, Vaughan JI, Moore GE (1998) Expression of the insulin-like growth factors and their receptors in term placentas: a comparison between normal and IUGR births. Mol Reprod Dev. 49:229-35. (Pubitemid 28080156)
22. Laviola L, Perrini S, Belsanti G, Natalicchio A, Montrone C, et al. (2005) Intrauterine growth restriction in humans is associated with abnormalities in placental insulin-like growth factor signaling. Endocrinology. 146(3):1498-1505. (Pubitemid 40289340)
23. Street ME, Viani I, Ziveri MA, Volta C, Smerieri A, et al. (2011) Impairment of insulin receptor signal transduction in placentas of intra-uterine growth-restricted newborns and its relationship with fetal growth. Eur J Endocrinol. 164(1):45-52.
24. Boura-Halfon S, Zick Y (2009) Phosphorylation of IRS proteins, insulin action, and insulin resistance. Am J Physiol Endocrinol Metab. 6(4):E581-91.
25. Peres SB, de Moraes SM, Costa CE, Brito LC, Takada J, et al. (2005) Endurance exercise training increases insulin responsiveness in isolated adipocytes through IRS/PI3-kinase/Akt pathway. J Appl Physiol (1985) 98(3):1037-43.
26. Wang CC, Adochio RL, Leitner JW, Abeyta IM, Draznin B, et al. (2013) Acute effects of different diet compositions on skeletal muscle insulin signalling in obese individuals during caloric restriction. Metabolism 62(4):595-603.
27. Ji P, Osorio JS, Drackley JK, Loor JJ (2012) Overfeeding a moderate energy diet prepartum does not impair bovine subcutaneous adipose tissue insulin signal transduction and induces marked changes in peripartal gene network expression. J Dairy Sci. 95(8):4333-4351.
28. Chen R, Kim O, Yang J, Sato K, Eisenmann KM, et al. (2001) Regulation of Akt/PKB activation by tyrosine phosphorylation. J Biol Chem. 276(34):31858-62.
29. Ma Y, Zhu MJ, Uthlaut AB, Nijland MJ, Nathanielsz PW, et al. (2011) Upregulation of growth signaling and nutrient transporters in cotyledons of early to mid-gestational nutrient restricted ewes. Placenta. 32(3): 255-263.
30. Aye IL, Jansson T, Powell TL (2013) Interleukin-1β inhibits insulin signaling and prevents insulin-stimulated system A amino acid transport in primary human trophoblasts. Mol Cell Endocrinol. 381(1-2):46-55.
31. Hasson SP, Rubinek T, Ryvo L, Wolf I (2013) Endocrine Resistance in Breast Cancer: Focus on the hosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Signaling Pathway. Breast Care (Basel). 8(4):248-255.
32. Watanabe R, Wei L, Huang J (2011) mTOR Signaling, Function, Novel Inhibitors, and Therapeutic TargetsJ Nucl Med 52 (4): 497-500.
33. Wullschleger S, Loewith R, Hall MN (2006) TOR signaling in growth and metabolism. Cell. 124:471-484. (Pubitemid 43199434)
34. Harlan SM, Guo DF, Morgan DA, Fernandes-Santos C, Rahmouni K (2013) Hypothalamic mTORC1 signaling controls sympathetic nerve activity and arterial pressure and mediates leptin effects. Cell Metab. 17(4): 599-606.
35. Sengupta S, Peterson TR, Sabatini DM (2010) Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress. Mol Cell. 40(2):310-22.